OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation
Anmada Nayak, Sarita Das, Deepika Nayak, et al.
Cellular Oncology (2019) Vol. 42, Iss. 2, pp. 157-171
Closed Access | Times Cited: 41
Anmada Nayak, Sarita Das, Deepika Nayak, et al.
Cellular Oncology (2019) Vol. 42, Iss. 2, pp. 157-171
Closed Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy, Chanakya Nath Kundu
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111285-111285
Open Access | Times Cited: 385
Chinmayee Sethy, Chanakya Nath Kundu
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111285-111285
Open Access | Times Cited: 385
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 319
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 319
Cancer stem cells and their unique role in metastatic spread
Teresa Bernadette Steinbichler, Dragana Savic, József Dudás, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 148-156
Closed Access | Times Cited: 93
Teresa Bernadette Steinbichler, Dragana Savic, József Dudás, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 148-156
Closed Access | Times Cited: 93
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 59
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 59
The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review
Wafa Bouleftour, Aline Guillot, Nicolas Magné
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 4, pp. 493-501
Open Access | Times Cited: 41
Wafa Bouleftour, Aline Guillot, Nicolas Magné
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 4, pp. 493-501
Open Access | Times Cited: 41
Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
Biswajit Das, Somya Ranjan Dash, Harun Patel, et al.
Phytomedicine (2023) Vol. 117, pp. 154914-154914
Closed Access | Times Cited: 16
Biswajit Das, Somya Ranjan Dash, Harun Patel, et al.
Phytomedicine (2023) Vol. 117, pp. 154914-154914
Closed Access | Times Cited: 16
Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment
S. Acharya, Chanakya Nath Kundu
Cancer Treatment Reviews (2024) Vol. 127, pp. 102749-102749
Closed Access | Times Cited: 6
S. Acharya, Chanakya Nath Kundu
Cancer Treatment Reviews (2024) Vol. 127, pp. 102749-102749
Closed Access | Times Cited: 6
PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)
Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla, et al.
Cellular Signalling (2020) Vol. 80, pp. 109902-109902
Closed Access | Times Cited: 42
Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla, et al.
Cellular Signalling (2020) Vol. 80, pp. 109902-109902
Closed Access | Times Cited: 42
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis
Chinmayee Sethy, Kunal Goutam, Biswajit Das, et al.
Vascular Pharmacology (2021) Vol. 140, pp. 106865-106865
Closed Access | Times Cited: 33
Chinmayee Sethy, Kunal Goutam, Biswajit Das, et al.
Vascular Pharmacology (2021) Vol. 140, pp. 106865-106865
Closed Access | Times Cited: 33
Theranostic Implications of Nectin-4 Oncoprotein in Gynecologic Cancers: A Review
Olivia Hooks, Yash Nagpal, Justin T Childers, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155913-155913
Closed Access
Olivia Hooks, Yash Nagpal, Justin T Childers, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155913-155913
Closed Access
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis
Xuecheng Shao, Xuehui Zheng, Dan Ma, et al.
Bioscience Reports (2021) Vol. 41, Iss. 7
Open Access | Times Cited: 31
Xuecheng Shao, Xuehui Zheng, Dan Ma, et al.
Bioscience Reports (2021) Vol. 41, Iss. 7
Open Access | Times Cited: 31
Nanotechnology-aided advancement in the combating of cancer metastasis
Leela Rani Avula, Piotr Grodzinski
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 2, pp. 383-404
Open Access | Times Cited: 19
Leela Rani Avula, Piotr Grodzinski
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 2, pp. 383-404
Open Access | Times Cited: 19
Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer
Yanting You, Qiuxing He, Hanqi Lu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 30
Yanting You, Qiuxing He, Hanqi Lu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 30
Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells
Subhajit Chatterjee, Chanakya Nath Kundu
European Journal of Pharmacology (2020) Vol. 883, pp. 173308-173308
Closed Access | Times Cited: 30
Subhajit Chatterjee, Chanakya Nath Kundu
European Journal of Pharmacology (2020) Vol. 883, pp. 173308-173308
Closed Access | Times Cited: 30
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul, et al.
Experimental Cell Research (2022) Vol. 420, Iss. 1, pp. 113338-113338
Closed Access | Times Cited: 18
Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul, et al.
Experimental Cell Research (2022) Vol. 420, Iss. 1, pp. 113338-113338
Closed Access | Times Cited: 18
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A
Deepika Nayak, Subarno Paul, Chinmay Das, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 609-626
Open Access | Times Cited: 17
Deepika Nayak, Subarno Paul, Chinmay Das, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 609-626
Open Access | Times Cited: 17
Nanotechnology-Aided Advancement in Combating the Cancer Metastasis
Arun Kumar Singh, Rishabha Malviya, Bhupendra G. Prajapati, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 899-899
Open Access | Times Cited: 9
Arun Kumar Singh, Rishabha Malviya, Bhupendra G. Prajapati, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 899-899
Open Access | Times Cited: 9
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
Saptarshi Sinha, Subarno Paul, S. Acharya, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 3
Saptarshi Sinha, Subarno Paul, S. Acharya, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 3
Role of Cancer Stem Cells in Drug Resistance
Kaneez Fatima, Shariqa Jan, Fayaz Malik, et al.
(2024), pp. 77-120
Closed Access | Times Cited: 3
Kaneez Fatima, Shariqa Jan, Fayaz Malik, et al.
(2024), pp. 77-120
Closed Access | Times Cited: 3
Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer
Dorothy Bhattacharjya, N Sivalingam
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
Dorothy Bhattacharjya, N Sivalingam
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
Tumour invasion and dissemination
Ryan Lusby, Philip D. Dunne, Vijay Tiwari
Biochemical Society Transactions (2022) Vol. 50, Iss. 3, pp. 1245-1257
Open Access | Times Cited: 15
Ryan Lusby, Philip D. Dunne, Vijay Tiwari
Biochemical Society Transactions (2022) Vol. 50, Iss. 3, pp. 1245-1257
Open Access | Times Cited: 15
Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer
Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 7, pp. 3011-3023
Closed Access | Times Cited: 23
Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 7, pp. 3011-3023
Closed Access | Times Cited: 23
WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway
Baohua Li, Xuedong Guo, Na Li, et al.
Cellular Oncology (2020) Vol. 43, Iss. 3, pp. 489-503
Open Access | Times Cited: 22
Baohua Li, Xuedong Guo, Na Li, et al.
Cellular Oncology (2020) Vol. 43, Iss. 3, pp. 489-503
Open Access | Times Cited: 22
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 7
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 7
Notch signaling in female cancers: a multifaceted node to overcome drug resistance
Maria Valeria Giuli, Angelica Mancusi, Eugenia Giuliani, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 16
Maria Valeria Giuli, Angelica Mancusi, Eugenia Giuliani, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 16
